Comparison
L-Theanine vs Omega-3 (EPA/DHA)
Side-by-side of L-Theanine and Omega-3 (EPA/DHA). Every row below is pulled from the compound schema and will update as our data grows. For deeper reads, follow through to each compound page.
L-Theanine
L-theanine is a non-protein amino acid found in tea leaves. The most-replicated nootropic; pairs with caffeine at 1:1 (100-200 mg each) for acute focus.
Omega-3 (EPA/DHA)
Omega 3 fish oil profile: EPA/DHA marine fatty acids, 2-4 g/day cuts triglycerides 20-30%, REDUCE-IT showed 25% cardiovascular risk reduction on icosapent eth.
Effects at a glance
L-Theanine
- •Non-protein amino acid in tea; the most-replicated nootropic in the human RCT literature
- •Caffeine + theanine at 1:1 (100-200 mg each) is the gold-standard acute focus stack
- •Solo doses of 200-400 mg reduce subjective stress and improve sleep quality
- •Increases alpha-wave EEG activity within 30-45 minutes of 200 mg oral dose
- •Crosses blood-brain barrier; bioavailability high, half-life 60-90 minutes
- •Clean safety record; minimal interactions at supplement doses
Omega-3 (EPA/DHA)
- •Reduces fasting triglycerides 20-50% at 2-4 g/day in hypertriglyceridemic patients
- •REDUCE-IT showed 25% relative risk reduction in major CV events at 4 g/day icosapent ethyl
- •Modest antidepressant effect (SMD ~0.40) for EPA-dominant formulations at 1-2 g/day
- •Atrial fibrillation incidence rises ~30-50% at 4 g/day; relevant for older patients with pre-existing CV disease
- •Tissue omega-3 index (RBC EPA + DHA) target ~8%; Western baseline typically 4-5%
- •Triglyceride and re-esterified triglyceride forms absorb ~70% better than ethyl esters in fasted state
Side-by-side
| Attribute | L-Theanine | Omega-3 (EPA/DHA) |
|---|---|---|
| Category | supplement | supplement |
| Also known as | theanine, gamma-glutamylethylamide | fish oil, EPA, DHA, marine omega-3 |
| Half-life (hr) ↗ | 1.5 | 48 |
| Typical dose (mg) ↗ | 200 | 2000 |
| Dosing frequency | as needed (with caffeine) or daily | 1 to 2 times daily with food |
| Routes | oral | oral |
| Onset (hr) | 0.5 | 4 |
| Peak (hr) | 1 | 12 |
| Molecular weight | 174.2 | 302.45 |
| Molecular formula | C7H14N2O3 | C20H30O2 (EPA); C22H32O2 (DHA) |
| Mechanism | Crosses BBB; modulates GABA/dopamine/serotonin (modest); increases alpha-wave EEG activity; dampens stress-induced sympathetic response without sedation. | Substitutes arachidonic acid in membrane phospholipids, shifting eicosanoid production toward less-inflammatory 3-series prostaglandins and 5-series leukotrienes. Activates PPAR-alpha to lower hepatic VLDL/triglyceride synthesis. DHA modulates synaptic membrane fluidity and neuronal function. |
| Legal status | OTC dietary supplement | Dietary supplement; prescription forms (icosapent ethyl, omega-3 acid ethyl esters) for severe hypertriglyceridemia |
| WADA status | allowed | allowed |
| DEA / Rx | OTC supplement | Not scheduled |
| Pregnancy | Insufficient supplement-dose data; tea-source intake safe | Recommended at 200 to 600 mg DHA/day for fetal development |
| CAS | 3081-61-6 | 10417-94-4 |
| PubChem CID | 439378 | 446284 |
| Wikidata | Q909931 | Q207688 |
Safety profile
L-Theanine
Common side effects
- mild GI upset (rare)
- headache (rare)
Contraindications
- pregnancy / lactation (insufficient data at supplement doses)
- concurrent strong GABAergics without caution
Interactions
- caffeine: synergistic for acute focus; dampens jitter without blunting alertness(minor)
- benzodiazepines / alcohol: potential additive sedation(minor)
Omega-3 (EPA/DHA)
Common side effects
- fishy aftertaste
- eructation (fish burps)
- mild dyspepsia
- loose stools at high doses
Contraindications
- fish allergy (use algal omega-3 alternative)
- active bleeding disorders
- scheduled surgery (discontinue 5-7 days prior)
Interactions
- warfarin and DOACs: additive antiplatelet effect at 2+ g/day; meaningful bleeding risk(moderate)
- aspirin and antiplatelet agents: additive bleeding risk at high doses(moderate)
- statins: complementary cardiovascular effects; no pharmacokinetic interaction(minor)
- antiarrhythmics: high-dose omega-3 increases AF risk; relevant in pre-existing arrhythmia(moderate)
Which Should You Take?
L-Theanine and Omega-3 (EPA/DHA) score evenly on the criteria we weight (goal breadth, legal accessibility, evidence depth). The conditionals below should drive the decision more than any aggregate score.
- → If your priority is stress and HPA-axis regulation, pick L-Theanine.
- → If your priority is sleep onset or sleep quality, pick L-Theanine.
- → If your priority is cardiovascular health, pick Omega-3 (EPA/DHA).
- → If your priority is healthspan extension, pick Omega-3 (EPA/DHA).
Edge case: Half-lives differ materially (L-Theanine ~1.5 hr vs Omega-3 (EPA/DHA) ~48 hr). Omega-3 (EPA/DHA) reaches steady state faster; L-Theanine is easier to dial in if tolerability is uncertain.
Default choice: either is defensible. L-Theanine edges out on goal breadth + legal accessibility; Omega-3 (EPA/DHA) is the right call if your priority sits in the goals listed above.
This verdict is generated from each compound's schema (goals, legal status, evidence outcomes, dosing route). It updates automatically as our compound data evolves; the deeper read sits on each individual compound page.
Common questions
What is the difference between L-Theanine and Omega-3 (EPA/DHA)?
L-Theanine and Omega-3 (EPA/DHA) differ in category (supplement vs supplement), mechanism, and typical dosing. See the side-by-side table for full details.
Which has a longer half-life, L-Theanine or Omega-3 (EPA/DHA)?
L-Theanine half-life is 1.5 hours; Omega-3 (EPA/DHA) half-life is 48 hours.
Can you stack L-Theanine with Omega-3 (EPA/DHA)?
Stack compatibility depends on mechanism overlap, legal status, and individual response. Check each compound page for specific interactions and contraindications before combining.
Go deeper